According
to the latest report published by Credence Research, Inc. “Global In-vitro
Diagnostics Market – Growth, Opportunities, Competitive Analysis, and Forecast,
2016 – 2022,” the in-vitro diagnostics
market was valued at USD
60,468.7 Mn in 2015, and is expected to reach USD 81,345.1 Mn by 2022,
expanding at a CAGR of 4.2% from 2016 to 2022.
Market
Insights
The
need for in-vitro diagnostics is on a consistent rise due to growing incidence
of chronic diseases, infections and high risk ageing population. Growing scope
of personalized medicine, molecular diagnostics and growing knowledge about
exploration of rare diseases and their treatments are further supporting the
growth of in-vitro diagnostics market. On the other hand, rigorous regulatory
requirements and dicey reimbursements will hold back the hold of this market.
Browse the
full report Global In-vitro Diagnostics Market @ http://www.credenceresearch.com/report/in-vitro-diagnostics-ivd-market
Reagents, instruments,
and software and services is the product level segmentation of the global
in-vitro diagnostics market. Among these, reagents take over 30% of the overall
market share in 2015, due to large scale consumption of these products across
all IVS techniques. Additionally, the software and services segment is
anticipated to progress at a faster growth rate during the forecast period
attributed by the growing need for widest automation and centralization of IVD
processes and techniques at a precision at par.
Molecular
diagnostics is observed to be the most remarkable IVD technique during the
forecast period. Growing applicability of MDx is attributed to its efficacy in
understanding disease mechanism and thus their vital role in discovery of
appropriate and targeted treatments. Its prospects in novel drug discovery and
personalized medicine also plays a critical role in facilitating lucrative
market growth during the forecast period. IVD is largely performed in central
laboratories, whereas its applicability in point-of-care testing is on a
perpetual growth. However, over-the-counter or self-testing IVD will
demonstrate the most significant growth rate in the near future with the
growing number of OTC testing products while offering cost effectiveness and
precise outcomes.
Request For Customization:
http://www.credenceresearch.com/report/in-vitro-diagnostics-ivd-market
Geographically,
North America is the largest in-vitro diagnostics market, with the region
taking over 35% market share in 2015. Fastest adoption of advanced technologies
and rapid adoption of automation techniques in diagnostic process are the prime
features of North America IVD market. Growing preference for molecular
diagnostic in cancer screening will also facilitate steady growth to North
America and Europe in-vitro diagnostics markets.
This
market is majorly dominated with 5 players taking over 5% market share. This
market is currently undergoing large scale consolidation activities by
multinational players. Emergence of regional players is another significant
phenomenon in the global in-vitro diagnostics market. Some of the major market
players include Abbott Laboratories, Inc., Johnson and Johnson, Becton, Dickson
and Company, Danaher Corporation, bioMérieux, Thermo Fisher Scientific, Inc.
Sysmex Corporation and others.
About
Us:
Credence Research is a worldwide market
research and counseling firm that serves driving organizations, governments, non-legislative
associations, and not-for-benefits. We offer our customers some assistance with
making enduring enhancements to their execution and understand their most
imperative objectives. Over almost a century, we’ve manufactured a firm
extraordinarily prepared to this task.
Media
Contact
Name:
Chris Smith (Global Sales Manager)
Address:
105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail:
sales@credenceresearch.com
Ph:
1-800-361-8290
Web: http://www.credenceresearch.com
This comment has been removed by the author.
ReplyDeleteThank You
ReplyDeleteVery Nice Information!!
Axiom Market Research & Consulting™ added a,
U.S. In Vitro Diagnostics Market Research Report By Type, Technique, Application and End User – Market Share,
Trend Analysis and Forecast up to 2024”.
The latest report by Credence Research, Inc. sheds light on the dynamic landscape of the Global In-vitro Diagnostics Market, revealing a market value of USD 60,468.7 Mn in 2015, with a projected growth to USD 81,345.1 Mn by 2022 at a CAGR of 4.2%. The rising demand for in-vitro diagnostics, fueled by increasing chronic diseases and an aging population, is evident. The report intelligently navigates through challenges, emphasizing the growing scope of personalized medicine and molecular diagnostics.
ReplyDeleteFor more in-depth insights, check out the full report at [HartBio](https://www.hartbio.co.uk/). This concise yet comprehensive analysis is a must-read for those keen on understanding the evolving landscape of in-vitro diagnostics.
This comment has been removed by the author.
ReplyDeleteThe latest report by Credence Research, Inc. sheds light on the dynamic landscape of the Global In-vitro Diagnostics Market, revealing a market value of USD 60,468.7 Mn in 2015, with a projected growth to USD 81,345.1 Mn by 2022 at a CAGR of 4.2%. The rising demand for in-vitro diagnostics, fueled by increasing chronic diseases and an aging population, is evident. The report intelligently navigates through challenges, emphasizing the growing scope of personalized medicine and molecular diagnostics.
ReplyDeleteFor more in-depth insights, check out the full report at hartBio This concise yet comprehensive analysis is a must-read for those keen on understanding the evolving landscape of in-vitro diagnostics.